Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NSE/LYKALABS stock hub

NSE/LYKALABS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/LYKALABSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.3B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/LYKALABS

In the news

Latest news · NSE/LYKALABS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/En/a

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC-0.7

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/LYKALABS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

156

Groups with data

Currency

INR

Showing 156 of 156 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	499
Employees Change	76%
Employees Change Percent	17.97
Enterprise value	INR 2.6B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Biotechnology
Isin	INE933A01014
Last refreshed	2026-05-10
Market cap	INR 2.3B
Price	INR 65.38
Price currency	INR
Rev Per Employee	2,610,148.3x
Sector	Healthcare
Sic	2834
Symbol	nse/LYKALABS
Website	https://www.lykalabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.33%
EV Earnings	-346.52x
EV/Sales	2.03x
P/B ratio	2.3x
P/S ratio	1.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.68%
EBITDA Margin	-2.04%
Gross margin	58.46%
Gross Profit	INR 761.4M
Gross Profit Growth	6.17%
Gross Profit Growth Q	-7.54%
Gross Profit Growth3 Y	13.1%
Gross Profit Growth5 Y	17.01%
Net Income	INR -7.6M
Net Income Growth Years	2%
Pretax Margin	-0.13%
Profit Margin	-0.5%
Profit Per Employee	INR -15,271
Profitable Years	1
Roa5y	7.59
ROIC	-0.67
Roic5y	12.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.36%
Cagr15y	7.4%
Cagr1y	-39.67%
Cagr20y	0.25%
Cagr3y	-13.68%
Cagr5y	10.86%
EPS Growth Years	2
Revenue Growth	1.9x
Revenue Growth Q	-9.08x
Revenue Growth Years	2x
Revenue Growth3 Y	10.55x
Revenue Growth5 Y	12.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 11.9M
Debt	INR 316.6M
Debt Equity	INR 0.31
Equity	INR 1B
Interest Coverage	-0.32
Net Cash	INR -304.7M
Net Cash By Market Cap	INR -13.06
Net Debt Equity	INR 0.3
Tangible Book Value	INR 930.6M
Tangible Book Value Per Share	INR 26.05
WACC	7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	6.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-12.83%
1Y total return	-39.65%
200-day SMA	81.43
3Y total return	-35.68%
50-day SMA	57.29
50-day SMA vs 200-day SMA	50under200
5Y total return	67.43%
All Time High	267
All Time High Change	-75.51%
All Time High Date	2021-12-24
All Time Low	8.15
All Time Low Change	702.21%
All Time Low Date	2011-12-21
ATR	3.18
Beta	0.5
Beta1y	0.67
Beta2y	0.45
Ch YTD	-13.85
High	65.38
High52	128.8
High52 Date	2025-05-29
High52ch	-49.23%
Low	62.27
Low52	44.1
Low52 Date	2026-03-30
Low52ch	48.25%
Ma50ch	14.11%
Price vs 200-day SMA	-19.71%
RSI	65.77
RSI Monthly	38.45
RSI Weekly	44.21
Sharpe ratio	-1.2x
Sortino ratio	-1.64
Total Return	6.95%
Tr YTD	-13.85
Tr15y	191.88%
Tr1m	11.17%
Tr1w	13.35%
Tr3m	-7.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -8.9M
Operating margin	-0.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,297,175%
Shares Insiders	14.33%
Shares Out	35,690,000
Shares Qo Q	-0.13%
Shares Yo Y	-6.95%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	29,841.6x
Bv Per Share	28.31
Ch10y	-12.83
Ch15y	191.9
Ch1m	11.17
Ch1w	13.35
Ch1y	-39.65
Ch20y	5.2
Ch3m	-7.45
Ch3y	-35.68
Ch5y	67.43
Ch6m	-30.5
Change	4.99%
Change From Open	4.99
Close	62.27
Days Gap	0
Depreciation Amortization	-17,678,250
Dollar Volume	1,789,712.1
Earnings Date	2026-05-22
EBIT	INR -8.9M
EBITDA	INR -26.5M
EPS	INR -0.22
F Score	1
Fiscal Year End	March
Founded	1,976
Income Tax	INR 1.7M
Is Primary Listing	1
Last Earnings Date	2026-01-29
Last Report Date	2025-12-31
Ma150	73.93
Ma150ch	-11.56%
Ma20	59.11
Ma20ch	10.61%
Next Earnings Date	2026-05-22
Open	62.27
Position In Range	100
Price Date	2026-05-08
Ptbv Ratio	2.51
Relative Volume	0.83x
Revenue	1,302,464,000x
Tax By Revenue	0.13x
Tr20y	5.2%
Tr6m	-30.5%
Volume	27,374

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/LYKALABS pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/LYKALABS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/LYKALABS?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+14.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-7.0%

Negative means the company is buying back shares.

Technical

NSE/LYKALABS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.8

Neutral momentum band

Price vs 200-day MA

-19.7%

50/200-day relationship not available

Beta (5Y)

0.50

Less volatile than the market

Sharpe ratio

-1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/LYKALABS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/LYKALABS stock rating?

nse/LYKALABS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/LYKALABS analysis?

The full report lives at /stocks/nse/LYKALABS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/LYKALABS?

The latest report frames nse/LYKALABS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/LYKALABS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.